Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
batten-disease
Press Release
Dec 23, 2019
Polaryx Therapeutics Submits Investigational New Drug Application to the U.S. FDA for the Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis With PLX-200
Read More
Press Release
Feb 26, 2018
Polaryx Therapeutics Received Orphan Drug Designation From the European Medicines Agency (EMA) for the Treatment of Neuronal Ceroid Lipofuscinosis With PLX-200
Read More
Press Release
Mar 22, 2012
Downers Grove, IL Charity Event
Noah's Hope - Fun In The Sun to Aid Two Siblings with Batten Disease, Terminal Between 8-12 years of Age.
Read More
First
Prev
1
Next
Last
